title: [Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
abstract: Efficacy and safety of sertraline (zoloft) have been assessed in 26 patients, aged from 7 to 15 years, with depressive states of different severity and psychopathological structure which are combined with obsessive-compulsive symptoms. Changes in patient's status are analyzed using psychometric scales during 6 weeks of treatment. It has been concluded that Zoloft is effective and safe drug for the treatment of mild to moderate depressive disorders concomitant to obsessive-compulsive disorders in children age.
authors.forename: A V
authors.initials: AV
authors.lastname: Goriunov
authors.forename: M V
authors.initials: MV
authors.lastname: Lobacheva
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D011594:Psychometrics; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D020280:Sertraline / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline